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Background/Aims
The development-processes by regional socio-cultural adaptation of an Enhanced Asian Rome III questionnaire (EAR3Q), a cul-
tural adaptation of the Rome III diagnostic questionnaire (R3DQ), and its translation-validation in Asian languages are 
presented. As English is not the first language for most Asians, translation-validation of EAR3Q is essential. Hence, we aimed 
to culturally adapt the R3DQ to develop EAR3Q and linguistically validate it to show that the EAR3Q is able to allocate diag-
nosis according to Rome III criteria. 
Methods
After EAR3Q was developed by Asian experts by consensus, it was translated into Chinese, Hindi-Telugu, Indonesian, Korean, 
and Thai, following Rome Foundation guidelines; these were then validated on native subjects (healthy [n = 60], and patients 
with irritable bowel syndrome [n = 59], functional dyspepsia [n = 53] and functional constipation [n = 61]) diagnosed by 
clinicians using Rome III criteria, negative alarm features and investigations. 
Results
Experts noted words for constipation, bloating, fullness and heartburn, posed difficulty. The English back-translated ques-
tionnaires demonstrated concordance with the original EAR3Q. Sensitivity and specificity of the questionnaires were high 
enough to diagnose respective functional gastrointestinal disorders (gold standard: clinical diagnoses) in most except Korean 
and Indonesian languages. Questionnaires often uncovered overlapping functional gastrointestinal disorders. Test-retest agree-
ment (kappa) values of the translated questionnaires were high (0.700-1.000) except in Korean (0.300-0.500) and Indonesian 
(0.100-0.400) languages at the initial and 2-week follow-up visit. 
Conclusions
Though Chinese, Hindi and Telugu translations were performed well, Korean and Indonesian versions were not. Questionnaires 
often uncovered overlapping FGIDs, which were quite common. 
(J Neurogastroenterol Motil 2015;21:83-92)
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Introduction
The functional gastrointestinal disorders (FGIDs) are com-
prised of a group of conditions that are currently defined by the 
presence of certain symptoms attributable to the gastrointestinal 
(GI) tract, in the absence of organic causes identifiable by routine 
investigations.1 To harmonize research in this field, a framework 
known as the Rome Criteria was developed to attempt classi-
fication of patients into diagnostic labels based putatively on the 
sites of the GI tract and the pathophysiological disturbances 
implicated.2 
However, these symptom-based diagnostic criteria, though 
led to substantial progress in research and care of patients with 
FGIDs, have limitations as there is lack of uniformity in so-
cio-cultural issues, languages, symptom reporting and spectrum 
of FGIDs across the world.3 Moreover, these criteria and ques-
tionnaires were written in English in the first iteration, and sub-
sequently translated into other languages. However, the nuances 
of some English wording may not be appreciated by non-English 
speakers and conversely, some regional terms may not have 
equivalent English word. As the identification and classification 
of FGIDs are dependent entirely on the ability of patients to de-
scribe and of the clinicians and investigators to interpret symp-
toms, we wonder if these criteria would do well in diagnostic allo-
cation, sub-typing and treatment assignment uniformly through-
out the world.4
In epidemiologic, pathophysiologic and therapeutic studies 
of FGIDs, the Rome Criteria have been applied almost univer-
sally. Epidemiological studies from Asia suggest that the preva-
lence and spectrum of FGIDs may differ in Asia compared to the 
West.3,5-12 There is growing interest to evaluate this issue in a more 
systematic manner in multi-national cross-cultural studies.13-15 
One of the barriers to such studies relates to the lack of a cultur-
ally adapted international questionnaire that has been translated and 
validated in various Asian languages using standard methods.16 As 
FGIDs are diagnosed by symptoms-based criteria,17,18 which are 
subject to psychosocial and socio-cultural influences,7,19,20 it is 
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Figure. Outline of the process of development of Enhanced Asian 
Rome III questionnaire (EAR3Q) from Rome III diagnostic 
questionnaire (R3DQ) and its translation and validation in different 
Asian languages. 
important that the terminologies used in the questionnaire are 
culturally adapted, so that the patients can understand their 
meanings clearly.13,14,21,22 Accordingly, we undertook a study 
with the following aims: (1) to develop a socio-culturally adapted 
questionnaire based on the Rome III diagnostic questionnaire 
(R3DQ),23 (2) to translate it into various Asian languages ac-
cording to the Rome Foundation guidelines,24 and (3) linguistic 
validation of the translated questionnaire to demonstrate that the 
various Asian translations of the Enhanced Asian Rome III ques-
tionnaire (EAR3Q) were able to allocate diagnosis according to 
the Rome III criteria.
Materials and Methods
The Study Protocol
This was a 3-phase prospective study involving experts with 
recent publications on FGIDs from 9 countries, mostly from 
Asia (2 of which are English-speaking, namely Singapore and 
USA). The organization of this study is presented in Figure. In 
the third phase of the study, the translated questionnaire has been 
field tested in a pan-Asian survey. However, in this report, we 
present the findings from phase 1 and 2 of this study. The find-
ings of the Asian FGID Study will be presented in separate 
manuscripts.
Phase 1: Development of Enhanced Asian 
Rome III Questionnaire From Rome III 
Diagnostic Questionnaire
These experts were tasked to evaluate the translatability of the 
R3DQ to the languages of their country. Specifically, we sought 
to identify questions that posed difficulty for patients to under-
stand the nuances pertaining to their English expression. The ex-
perts were encouraged to conduct cognitive interviews with their 
patients to understand how the relevant questions were inter-
preted.
The working groups were organized according to the way the 
R3DQ was divided into anatomical sections, ie, esophagus, stom-
ach and intestines, gallbladder or pancreas and rectum or anal 
canal. The working groups were tasked to examine the adequacy 
of the questions to describe the Asian person’s pattern of symp-
tom reporting for the sections they were assigned. At a round-ta-
ble meeting, the experts presented their findings. The R3DQ was 
reviewed question by question. For the questions that were iden-
tified to be difficult for an Asian patient to understand, new ques-
tions were developed taking account of socio-cultural factors and 
encompassing the nuances of Asian languages. New questions 
were also developed for symptoms where it was found that exist-
ing questions were inadequate for describing Asian patients’ and 
physicians’ clinical encounters. In the new questions we used 
neutral terms to describe patients’ symptom experiences, as much 
as possible. The new questions will be referred to as Asian adapt-
ed questions. To maintain compatibility with the R3DQ and to 
allow for comparison with earlier studies, we retained all the orig-
inal questions in their original wording, but positioned the Asian 
adapted questions directly after each of the original question. The 
combination of the R3DQ with the Asian adapted questions was 
named the EAR3Q, which is presented in the Supplementary 
Table 1.
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Phase 2: Translation-Validation of Enhanced 
Asian Rome III Questionnaire Into Various 
Languages
From January to December 2011, The EAR3Q was trans-
lated into the following languages: Chinese, 2 Indian (Hindi and 
Telugu), Indonesian, Korean, and Thai. These translations were 
then tested on a prospective sample of patients speaking these 
languages and suffering from irritable bowel syndrome (IBS), 
functional dyspepsia (FD) and functional constipation (FC), as 
well as native healthy subjects (HS). Translation-validation was 
conducted according to the Rome Foundation guidelines for new 
language translations.21
The process of translation of the Enhanced Asian Rome 
III questionnaire
EAR3Q was translated into each language by 2 independent 
translators separately (Asian versions 1a and 1b, Figure). Subse-
quently, the 2 versions were reconciled by another expert well- 
conversant in the respective language to create a final translated 
questionnaire (Asian version 2), which was back translated into 
English by another qualified expert well-conversant in both 
languages. The original and the backward English versions of the 
questionnaire were assessed for similarity of language and com-
parability of interpretation, and where necessary, revisions and 
modifications were made to the Asian version to produce Asian 
version 3. The final Asian versions 3 in different languages are in 
Supplementary Tables 2-7.
Validation of the translated questionnaires
After the process of translation as described above, the ques-
tionnaires were validated on the HS and patients with IBS, FD, 
and FC (diagnosed by clinicians using Rome III criteria as in 
practice setting, by symptoms, negative alarm features17,18 with 
exclusion of organic disease with appropriate investigations, 
which is considered as the gold standard) belonging to respective 
nations and speaking respective language as their native 
language. The diagnosis of each group of patients with FGID 
was made initially by the clinician as he/she would do in his/her 
clinical practice by interview using the Rome III criteria, and in-
vestigating alarm features where these were present. 
Subsequently, the patients were asked to fill in the translated 
questionnaire. Each subject was asked to fill in the questionnaire 
himself/herself. However, in most centres, a research assistant sat 
with the subject at the time of filling the questionnaire. Exclusion 
criteria of patients included presence of alarm symptoms, the 
cause for which had not been verified with appropriate 
investigations. After a 2-week period, subjects were asked to re-
peat the questionnaire to check for its reproducibility. 
Supplemental questions, as detailed in Supplementary Table 1, 
were not included when questionnaire-based diagnoses were 
compared to the clinical diagnoses. The study protocol was ap-
proved by the Ethics Committee of the respective Institutes. 
Informed consent was obtained from each subject. 
Statistical Methods
The categorical and continuous data are presented as pro-
portion, median and range, respectively. We assessed the validity 
of the questionnaire by examining its sensitivity to pick-up clini-
cians’ diagnoses (considered as gold standard) at the initial visit. 
If the questionnaire picked-up the diagnoses made by the clini-
cian, the result was considered true positive and if not, it was con-
sidered false negative. For calculation of specificity, the pro-
portion of healthy subjects labelled as healthy was considered. 
The test-retest reliability analysis involved re-testing subjects af-
ter 2 weeks. The agreement between diagnoses made at different 
time points by the questionnaire was evaluated by kappa statistics. 
Values for kappa > 0.810 were considered excellent agreement, 
between 0.610-0.800 as good agreement and those below < 
0.600 as poor agreement.
Results
Phase 1: Results of Study on Development 
of Enhanced Asian Rome III Questionnaire 
From Rome III Diagnostic Questionnaire
While evaluating the translatability of questions in the 
English version of the R3DQ, to the language of their country, 
the experts identified difficulty with the questions on globus, dys-
phagia, odynophagia, anal blockage and digital manoeuvres. 
These questions together with the reasons for difficulty and the 
adapted questions that we propose are presented in the Supple-
mentary Table 8 as R3DQ Q No. 3, 4, 56, and 57. 
While examining the adequacy of the original questions for 
describing the Asian person’s pattern of symptom reporting, the 
experts identified that complaints about excessive gas as well as 
symptoms associated with gas (belching, fullness and bloating) 
were highly prevalent. The existing questions in the R3DQ were 
considered to be insufficient to elucidate the association between 
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these symptoms and gas. It was also brought to attention that the 
term used to describe constipation in many of Asian languages 
(Chinese and Korean) was literally translated to mean difficulty in 
releasing stools. There were insufficient questions in R3DQ to 
explore the understanding and perception of this Asian concept 
on the term constipation. The additional questions developed to 
probe deeper into the characteristics of these symptoms are pre-
sented in the Supplementary Table 8 as R3DQ Q No. 14, 40, 56, 
57 and 66.
The experts also reported that fullness and bloating were very 
common complaints among patients in whom they had made a 
clinical diagnosis of IBS. In some countries, the experts felt that 
bloating was more common than abdominal pain. It was further 
observed that many of these patients reported relief of their full-
ness or bloating with the passage of either stool or flatus. 
Therefore, options were added to elucidate the effects of passing 
stools and of passing flatus to R3DQ Q No. 14 and 66 (Supple-
mentary Table 8).
The experts felt the need for a diagrammatic or pictorial rep-
resentation to enable the interviewer to capture the desired in-
formation better in relation to the area related to location of ab-
dominal pain; in R3DQ Q No. 17 and 68, patients were asked if 
they had experienced pain in the epigastrium or right hypo-
chondrium. The experts observed that their patients had diffi-
culty understanding the descriptions given on these 2 locations. 
Therefore, in these questions, a diagram of the abdomen divided 
into the standard nine quadrants was included. 
Discrepancy was observed between verbal descriptors and 
patients’ perceptions in relation to stool form. According to Rome 
or recently proposed Asian criteria,25 stool form is important to 
define constipation rather than frequency. Whereas Rome III 
criteria define Bristol types 1 or 2 stool forms as constipation, 
Asian criteria include type 3 stool as well to define constipation.25 
Therefore, considering the importance of stool form to define 
constipation, a pictorial diagram of the Bristol stool scale was in-
cluded to R3DQ Q No. 62 to overcome ambiguity arising from 
verbal descriptors. We extended this question to incorporate 
questions that would allow us to encompass patients’ perceptions 
of their bowel habits, of what stool forms constitutes constipation, 
diarrhoea and a healthy bowel habit. 
No change was made to the scoring algorithm; the frequency 
and severity scales in the RD3Q were retained for all the 
questions. However, for some of our new questions we added op-
tions that seek to relate the timing of symptoms to meals. For ex-
ample, we considered that the question relating to globus (R3DQ 
Q No. 3) was ambiguous, as it could be interpreted to refer to 
dysphagia. Therefore, options were added to define the timing in 
relation to meals. We also added a scoring that takes into account 
the size of a meal for the question on post-prandial fullness 
(R3DQ Q No. 14). 
Phase 2: Results of Translation-Validation Study
The translated questionnaire
The translated questionnaires had high concordance with the 
original English EAR3Q. Supplementary Tables 2-7 presents 
the reconciled version of the questionnaire in different Asian lan-
guages used in further validation studies. The understandability 
of the questionnaire by patients was not systematically inves-
tigated by cognitive debriefing. While administering the ques-
tionnaire during the validation study, many HS and the patients 
reported that questions were easily understood. However, most 
subjects reported that the questionnaire was quite lengthy. Time 
needed to complete the questionnaire was quite long as per data 
from 4 centers (median 35 [range 15-90] minutes).
Demographic and clinical variables of the study subjects
Table 1 presents data on demographic and clinical parame-
ters of HS, patients with IBS, FD, and FC included in the vali-
dation studies. 
Result of validation of the translated questionnaires
Table 2 presents the data on result of validation studies on 
translated questionnaires (sensitivity and specificity to pick-up 
clinical diagnoses and kappa values for test-retest agreement). 
Sensitivity and specificity of the questionnaires were high (60- 
100%) to diagnose respective FGIDs (gold standard: clinical di-
agnoses) in most except Korean (27-67%) and Indonesian 
(30-60%) languages. Test- retest agreement (kappa) values of the 
translated questionnaires were variable. The Hindi, Telugu, and 
Chinese questionnaires had high concordance (kappa value 0.700- 
1.000) between the initial questionnaire-based diagnosis and that 
on 14th day. However, concordance for the Korean and Indone-
sian questionnaires varied between 0.100 and 0.500 and for the 
Thai questionnaire was 0.800. Diagnostic performance of the 
Indonesian and Korean questionnaires was particularly low for 
FC, IBS, and FD (Table 2). In the Korean cohort, patients who 
had been categorized by their doctors to have FD showed partic-
ularly low concordance (only 3/11, 27%) with the outcome based 
on the patients’ responses to the EAR3Q; 4/11 (36%) were found 
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Table 1. Number of Healthy Subjects, Patients With Irritable Bowel Syndrome, Functional Dyspepsia, and Functional Constipation Included in 
Validation Study and Their Demographic Parameters
Demographic parameters Healthy subjects Irritable bowel syndrome Functional constipation Functional dyspepsia
Hindi validation study n = 10 n = 10 n = 10 n = 10
   Age (median [range], yr) 26 (21-56) 33 (17-53) 45.5 (18-66) 49.5 (26-65)
   Gender (M:F) 4:6 8:2 3:7 7:3
Telegu validation study n = 10 n = 11 n = 6 n = 8
   Age (median [range], yr) 25.5 (23-30) 33.0 (18-62) 42 (24-55) 45.5 (24-63)
   Gender (M:F) 4:6 11:0 5:1 3:5
Chinese validation study n = 6 n = 9 n = 14 n = 9
   Age (median [range], yr) 26.5(24-47) 46(24-65) 41(20-59) 42(23-65)
   Gender (M:F) 2:4 3:6 8:6 4:5
Korean validation study n = 14 n = 9 n = 11 n = 6
   Age (median [range], yr) 36.5 (24-52) 37 (27-48) 33 (31-65) 38 (21-58)
   Gender (M:F) 5:9 6:3 4:7 0:6
Indonesian validation study n = 10 n = 10 n = 10 n = 10
   Age (median [range], yr) 32.8 (21-62) 46.9 (22-72) 43.1 (26-63) 45.2 (22-67)
   Gender (M:F) 5:5 7:3 1:9 1:9
Thai validation study n = 10 n = 10 n = 10 n = 10
   Age (median [range], yr) 44 (26-66) 45 (24-63) 46.5 (37-65) 53 (14-62)
   Gender (M:F) 3:7 2:8 3:7 1:9
Total number of subjects 60 59 61 53
to qualify IBS-criteria and another 2 (18%) as functional bloating, 
while 5 (46%) did not fulfil any specific FGID diagnosis. Some of 
the patients diagnosed as FC failed to meet the criteria on filling 
the questionnaire. In some languages, such as Hindi and 
Chinese, the questionnaire often uncovered symptoms of asso-
ciated disorders such as FD among patients with IBS and FC 
and IBS among patients with FD both at the initial and at the 
2-week follow-up visits (Table 2). 
Discussion
In this study, a group of Asian FGID experts developed a so-
cio-culturally adapted questionnaire (EAR3Q) for evaluating pa-
tients with FGIDs in Asia from R3DQ by consensus. Moreover, 
these experts, who are conversant with the target languages, 
translated and validated the EAR3Q into Chinese, Hindi-Telugu, 
Korean, Indonesian, and Thai following the guidelines for-
mulated by the Rome Foundation.21,24 Culturally adapting the 
questionnaire has been recommended21 to achieve conceptually 
equivalent meaning and intent of the original instrument. There 
are cultural contexts and linguistic nuances in Asian languages 
that have potentially important impact on the interpretation of 
symptoms relating to the FGIDs. 
We found that the nuances of some English wording were 
not appreciated by non-English speakers, eg, hurt to swallow, 
food or drinks get stuck after swallowing (stuck where?), and 
mushy stools. In most of the Asian languages, exact equivalent 
words are lacking for terms like heartburn and bloating. More-
over, there was overlap in the terms or words used to describe 
fullness, bloating and distension. For example, the Chinese word 
“zhang” is used to describe distension, but this word is also used 
to describe bloating and fullness. 
In one study from China, when comparing between patients 
with FD alone and patients who were classified as FD-IBS over-
lap based on the Rome III criteria, post-prandial fullness pre-
dicted the presence of co-existing IBS.26 We suspect that some of 
these patients might not have experienced fullness, but instead 
were experiencing bloating, and could have been classified as IBS 
alone without FD overlap. In another study from Taiwan, about 
half of the patients initially classified as having FD, were found to 
have pure IBS, when it was confirmed that the sensations they 
had reported in the upper abdomen were relieved by defecation.27
In contrast to Western patients with IBS who localize pain 
more frequently to the lower abdomen, Asian patients often ap-
pear to localize their pain more frequently to the upper abdo-
men.28 In some Asian cultures, food and nutrition have tradition-
ally been viewed as an important aspect of health and of illness. 
For example, “The Chinese do not draw any distinction between food 
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Table 2. Diagnostic Performance of Translated Versions of Enhanced Asian Rome III Questionnaires
Clinical diagnostic category
Concordance between clinical 
and questionnaire-based 
diagnosis on initial visit
Sensitivity Specificity
Concordance of  the 
questionnaire between initial 
and 14th day visit
Kappa 
(EAR3Q-based 
diagnoses at initial 
and 2-week 
follow-up)
Hindi HS (n = 10) 10 100% 100% 10 1.000
IBS (n = 10) 10
7 (70%) had FD symptoms also
100% 10  
7 (70%) had FD symptoms also
1.000
FC (n = 10) 10
9 (90%) had FD symptoms also
100% 10 
9 (90%) had FD symptoms also
1.000
FD (n = 10) 10
6 (60%) had IBS symptoms also
100% 10 
4 (40%) had IBS symptoms also
1.000
Telugu HS (n = 10) 10 100% 100% 10 1.000
IBS (n = 11) 11
3 (27%) had FD symptoms also
100% 11 
2 (18%) had FD symptoms also
1.000
FC (n = 6) 6 
1 (17%) had FD symptoms also
100% 6 
1 (17%) had FD symptoms also
1.000
FD (n = 8) 8 100% 8 1.000
Chinese HS (n = 6) 6 100% 100% 6 1.000
IBS (n = 9) 9 100% 7 (77.8%) 0.700
FC (n = 9) 9 
1 (11%) had FD symptoms also
100% 8 0.900
FD (n = 14) 14
5 (35.7%) had FC symptoms also
100% 10
2 (20%) had FC symptoms also
1 (10%) had IBS  symptoms also
0.700
Korean HS (n = 14) 13 (93%)   93%   93% 14 1.000
IBS (n = 9) 5 
1 (11%) had FD and 1 (11%) had 
functional bloating also and 4 did not 
fulfil criteria for any specific FGIDs
55.5% 4 
1 had FD and 4 did not fulfil criteria 
for any specific FGIDs
0.400
FC (n = 6) 4 
2 (33%) had functional bloating also, 
1 IBS and 1 did not fulfil criteria for 
any specific FGIDs
  67% 3 
1 (17%) had FD also and 3 had IBS
0.500
FD (n = 11) 3 
3 (27%) had IBS also, 2 functional 
bloating, 1 IBS only and 5 did not 
fulfil criteria for any specific FGIDs
  27% 3 
3 (27%) had IBS also and 2 had 
functional bloating, 2 had IBS, and 4 
did not fulfil criteria for any specific 
FGIDs
0.300
Indonesian HS (n = 10) 9   90%   90% 9 0.900
IBS (n = 10) 6
3 had FD symptoms also
  60% 3 
2 had FD symptoms also
0.300
FC (n = 10) 3
2 had FD symptoms also
  30% 1 0.100
FD (n = 10) 4
3 had IBS symptoms also
  40% 4 
1 had IBS
0.400
Thai HS (n = 10) 9   90%   90% 8 0.800
IBS (n = 10) 6   60% 8 0.800
FC (n = 10) 6
1 had IBS and 1 FD had symptoms also
  60% 8 0.800
FD (n = 10) 8
1 (10%) had functional bloating also
  80% 8 
1 (10%) had functional bloating also
0.800
EAR3Q, Enhanced Asian Rome III questionnaires; HS, healthy subject; IBS, irritable bowel syndrome; FC, functional constipation; FD, functional dyspepsia.
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and medicine.”29 It is conceivable that this cultural perspective 
could influence patients to perceive disturbed functions of the 
stomach as the origin of their symptoms. 
We also observed that many of our patients in whom we 
make a clinical diagnosis of IBS may fail to fulfil Rome Criteria 
because they do not complain of pain.4 Across the Asian coun-
tries, we found that bloating was a dominant complaint among 
patients with IBS.3 It is possible that some of these patients may 
label their abdominal pain or discomfort as bloating. In a study by 
Gerson et al,30 significant positive correlations between the se-
verity of abdominal pain and bloating were found across 7 coun-
tries (USA, Mexico, Canada, England, Italy, Israel, and India); 
this suggests that IBS subjects in these countries conceptualize 
pain and bloating as different but related concomitants of gastro-
intestinal disturbance. 
The Rome Criteria indicate that hard stool refers to either 
Bristol type 1 or 2. However, in a study from South Korea, close 
to three-quarters of patients with IBS who had verbally reported 
passing hard stools, failed to meet this criteria.31 We found some 
evidence that point to a relatively shorter colonic transit time 
among Asians compared with those reported in the West, both 
for healthy volunteers as well as subjects with constipation.3,25 To 
allow the patient’s perspectives to be taken into consideration, we 
introduced a new approach of asking patients what type of stools 
were passed when they felt they were experiencing constipation, 
diarrhoea or normal bowel habits. Furthermore, we sought to ex-
plore the Asian peoples’ concepts of constipation, by extending 
the questions on anal blockage by asking their perception of the 
stool characteristics when it was difficult to pass.
In validation study of the translated questionnaires, the diag-
nostic performance of Chinese, Hindi, and Telugu translations 
of the EAR3Q was high. Among all the translations, Korean and 
Indonesian translated EAR3Q often failed to diagnose several 
specific FGIDs although these questionnaires performed well in 
categorizing HS as healthy. This might be related to the fact that 
the physicians made the diagnosis without global evaluation for 
different subtypes of FGIDs, and therefore, in busy clinic, tend-
ed to overlook overlapping FGIDs. Other reasons may be related 
to recall bias by the patients on symptom duration and limitations 
of Rome III criteria. Moreover, small sample size in the present 
study might have over-estimated the frequency of overlap 
syndromes. In the Korean cohort, patients who had been catego-
rized by their doctors to have FD showed particularly low con-
cordance (only 3/11, 27%) with the outcome based on the pa-
tients’ responses to the EAR3Q; 4 (36%) were found to qualify 
as IBS and another 2 (18%) as functional bloating, while 5 (46%) 
did not fulfil any specific FGID diagnosis. This may reflect the 
failure of the doctors to enquire about bowel habits in the patients 
that they had diagnosed as FD, rather than failure of EAR3Q. In 
fact, this is one of the major diagnostic issue that we encounter in 
Asia where physicians frequently appear to mis-diagnose IBS as 
FD.3 This scenario is consistent with the observations by Lu et 
al,27 that half of all patients presenting with upper abdominal 
symptoms who had received an initial diagnosis of FD were 
found on detailed questioning to have upper abdominal symp-
toms fulfilling IBS criteria. Similarly in the Indonesian cohort we 
found that only 40% of patients given a diagnosis of FD by their 
doctors fulfilled these criteria based on the questionnaire, while 
30% achieved criteria for IBS in their questionnaire. Another 
poor performer was in FC where only 30% of patients who were 
thought by their doctors to have FC were able to satisfy Rome III 
criteria based on the questionnaire. One possible explanation is 
the discrepancy between the patients’ perception which places im-
portance to hardness of stool and incomplete evacuation, and the 
physicians’ concept of constipation which emphasizes infrequent 
bowel movement.32 In a study from South Korea it was observed 
that close to three-quarters of patients who complained of hard 
stools failed to meet Rome criteria for hard stools.31 There are 
studies from Asia which point to shorter colonic transit times rel-
ative to those reported from the West.3 Thus, some of the dis-
cordance that we observed in our validation study may be due to 
important and relevant socio-cultural and even physiological dif-
ferences between the East and the West. 
We, for the first time, developed EAR3Q and successfully 
translated and validated it in several Asian languages. There was 
a good degree of understandability among the volunteers, a high 
sensitivity and specificity to diagnose various FGIDs and the 
test-retest reliability in Hindi-Telugu and Chinese questionnaire; 
these suggest that these translations were successful. Thai ques-
tionnaire also performed reasonably well. However, the Korean 
and Indonesian questionnaires were not found as valid and may 
require additional work to improve their test statistics. With the 
current trend of increasing number of drug trials in non-English 
speaking areas of world, importance of such translation cannot be 
over-estimated. The translated questionnaires in various Asian 
languages will be made available for use by other workers in the 
field. The busy clinicians may also use these questionnaires in 
clinical practice for global evaluation of patients with FGIDs, 
which will help them to particularly recognize the overlapping 
conditions that may have important bearing on treatment. 
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A few limitations of the current study are worth mentioning. 
The questionnaire is expected to work better in younger and 
more educated people than older and less educated people. The 
HS included in all the validation studies except in Korea and 
Thailand were younger than the patients (Table 1). For less edu-
cated people, developing questionnaires with pictorial representa-
tions may be more useful. Some of the Asian languages have dif-
ferent dialect and pronunciations. People of rural areas may have 
somewhat variant understanding of some words than those in ur-
ban areas. For test-retest reliability, 2-week interval may be short 
and even may result in learning effect leading to different result. 
Small sample size in validation study is another limitation. It is 
however, under further validation in a large sample of patients 
with FGIDs in an Asian FGIDs survey, which will be published 
as separate papers. We believe, though not substantiated by the 
data, that these limitations are unlikely to be major limitations. 
The questionnaire was able to identify overlapping FGIDs 
quite often that the clinicians had missed. This is not entirely un-
expected as firstly, overlap syndromes are common,3,6,33-36 and 
secondly, physicians in a busy clinic may choose to focus only on 
the most bothersome symptom. Since overlap between various 
types of FGIDs is common3,6,33-36 and since this may have ther-
apeutic and prognostic importance,37 the use of a diagnostic ques-
tionnaire may help busy clinicians to completely evaluate patients 
with FGIDs. 
In conclusion, we have successfully developed a socio-cultur-
ally adapted questionnaire and translated it in several major Asian 
languages (Hindi-Telugu, Chinese, Korean, Indonesian and 
Thai). We believe that a culturally adapted questionnaire that 
takes into account the linguistic nuances and socio-cultural per-
spectives, is an important first step towards describing a true pic-
ture of FGID in Asia.
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